Stay updated on Pembrolizumab in Glioblastoma Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab in Glioblastoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab in Glioblastoma Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Difference
    0.1%
    Check dated 2025-05-07T19:39:14.000Z thumbnail image
  2. Check
    8 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.15.0 to version 2.15.2, indicating a revision in the content.
    Difference
    0.2%
    Check dated 2025-04-30T14:21:33.000Z thumbnail image
  3. Check
    15 days ago
    No Change Detected
  4. Check
    22 days ago
    Change Detected
    Summary
    The page has undergone significant updates, including the removal of detailed descriptions of a clinical trial for glioblastoma and the addition of new identifiers and a location for the study. The revision number has also been updated.
    Difference
    62%
    Check dated 2025-04-16T10:20:17.000Z thumbnail image
  5. Check
    30 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.14.3 to version 2.14.4.
    Difference
    0.1%
    Check dated 2025-04-09T04:59:27.000Z thumbnail image
  6. Check
    37 days ago
    Change Detected
    Summary
    The web page has been updated to version 2.14.3, replacing the previous version 2.14.2.
    Difference
    0.1%
    Check dated 2025-04-01T22:20:46.000Z thumbnail image
  7. Check
    66 days ago
    Change Detected
    Summary
    The page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.
    Difference
    1%
    Check dated 2025-03-03T22:55:36.000Z thumbnail image

Stay in the know with updates to Pembrolizumab in Glioblastoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in Glioblastoma Clinical Trial page.